Mereo BioPharma Appoints Wills Hughes-WilsonMereo BioPharma Group plc, a multi-asset biopharmaceutical company focused on the acquisition, development and commercialization of innovative therapeutics that aim to improve outcomes for patients with … more ➔
Sigurdur Olafsson appointed CEO of HikmaHikma Pharmaceuticals today announces its Board of Directors has appointed Sigurdur (Siggi) Olafsson as Chief Executive Officer. Mr Olafsson will also join Hikma’s Board of Directors as an executive … more ➔
Addex Appoints Jean-Philippe Rocher as Co-Head DiscoveryAddex Therapeutics, a leading company in allosteric modulation-based drug discovery and development, announced today the appointment of Jean-Philippe Rocher, PhD, as Co-Head of Discovery and Member of … more ➔
Selvita appoints new Chief Medical OfficerSelvita S.A., a clinical stage drug discovery and development company focused on innovative medicines for oncology patients and drug discovery services, announced today the appointment of Steffen Heeger, … more ➔
Rentschler Biopharma SE appoints Dr. Ralf Otto as COORentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February … more ➔
Storm Therapeutics Appoints Nobel Prize Winner Thomas Cech as Scientific AdvisorStorm Therapeutics today announced the appointment of Nobel Prize Winner Professor Thomas Cech as a Scientific Advisor. This appointment follows STORM Therapeutics’ successful Series A Financing Extension … more ➔
Congenica Appoints New CEOCongenica, a global provider of clinical genomics interpretation software, today announced the appointment of its new Chief Executive Officer David Atkins, Ph.D. Based at the Company’s headquarters in … more ➔
Emil Billbäck appointed CEO of BONESUPPORTBONESUPPORT (Nasdaq Stockholm: BONEX) announces that the Board of Directors has appointed Emil Billbäck as the new CEO of BONESUPPORT HOLDING AB. Mr. Billbäck has over 20 years management experience … more ➔
Synpromics Appoints Sarah Haecker Meeks as VP of BDSynpromics Ltd today announced the appointment of Sarah Haecker Meeks, PhD to the position of Vice President, Business Development. more ➔
Glythera appoints Chief Scientific OfficerGlythera Limited is pleased to announce the appointment of Dr Robert Lutz as Chief Scientific Officer. Dr Lutz will lead the advancement of Glythera’s portfolio of Antibody Drug Conjugates (ADCs) in … more ➔
